Navigation Links
Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cancers

PITTSBURGH, June 6, 2011 /PRNewswire/ -- Dr. Bradley Monk of the Creighton University School of Medicine presented a new gynecologic cancer study at the 2011 American Society of Clinical Oncology (ASCO) Annual Symposium, June 5th in Chicago, Illinois.  The study, titled, Acquired Drug Resistance in Gynecologic Cancer Detected by an In Vitro Assay, begins to answer the question of whether ChemoFx® Drug Response Marker test results taken in the primary setting can be utilized for predicting chemotherapeutic response in the recurrent setting.

To evaluate changes in chemosensitivity, ChemoFx® testing was performed on 30 patient specimens in both the primary and recurrent setting.  Test results were then analyzed to observe the development of resistance to commonly-utilized treatments for recurrent gynecologic cancers.  A significant shift towards resistance was found in the agents carboplatin and paclitaxel, but a significant shift was not observed in other agents studied.  The shift in response for carboplatin and paclitaxel may be attributed to a combination of the two agents being a NCCN® Guideline-recommended first-line therapy for primary ovarian cancer patients.

Though this shift towards resistance should be taken into consideration if a metastatic specimen is available for reanalysis, ChemoFx® results for agents not commonly used as first-line therapies were consistent in both the primary and recurrent setting.  This supports the utility of marker results obtained in the primary setting for assisting in treatment decisions when tissue is not available at the time of recurrence.

"This study suggests that ChemoFx® is able to parallel the clinical portion of ovarian cancer treatment that is associated with predicting which drugs are active in targeting optimal chemotherapy," says Dr. Bradley Monk, Professor in the division of Gynecological Oncology at Creighton University School of Medicine. "Over 1 million cases per year in the U.S. alone are treated with chemotherapy through a 'trial and error' based approach and targeting which agents are most likely to predict response is a major stride in personalizing medicine."

About Precision Therapeutics

Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to personalized cancer care.  Precision offers a portfolio of products developed to help guide physicians and patients with difficult clinical decisions throughout the cancer care continuum.

Precision's state of the art bioinformatics combined with the analysis of the live molecular, proteomic and genomic activity of each patient's cancer offer an innovative foundation for further development and commercialization of novel predictive markers for cancer therapy. 

About ChemoFx®

Precision's first commercial test, ChemoFx®, is a proprietary drug response marker which measures an individual's malignant tumor response to a range of standard therapeutic alternatives under consideration by a physician. For more information, please visit, or

SOURCE Precision Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
2. Applied Precision Announces New Products for Life Sciences Microscopy at the 110th American Society for Microbiology Meeting in San Diego, CA, May 23-26th.
3. Precision Bearing Technologies Featured at Atlantic Design & Manufacturing Show
4. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
5. Applied Precisions Mobile Imaging Lab Hits the Road for a Cross-Country Journey
6. Clinical Experts Detail How They Use Varians TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments
7. Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award
8. Applied Precision Installs a Record Four New DeltaVision OMX Super-Resolution Imaging Systems in Eight Weeks
9. Exempla Saint Joseph Hospital Commences Treating Cancer Patients Using New TrueBeam™ System for High-Precision Image-Guided Radiotherapy and Radiosurgery
10. Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico
11. Applied Precision Scientific Team to Present 3D-SIM Paper at BiOS in San Francisco
Post Your Comments:
(Date:10/13/2015)... , Oct. 13, 2015  The spine division ... leader in musculoskeletal healthcare, will showcase its portfolio of ... Spine Society (NASS) annual meeting, October 14-17, 2015, in ... also host two clinical events: "Supplemental MIS ... Presentation Wednesday, October 14 12:30 – 1 p.m. ...
(Date:10/13/2015)... N.J. , Oct. 13, 2015  ContraVir ... the "Company"), a biopharmaceutical company focused on the ... announced the closing of its previously announced underwritten ... stock and warrants to purchase up to 3,000,000 ... fixed combined price to the public of $3.00. ...
(Date:10/13/2015)... JOLLA, Calif. , Oct. 13, 2015  Human ... revolutionize the practice of medicine, announced today the launch ... clinical research project that has the potential to transform ... San Diego, CA , at HLI,s headquarters ... in 2016 in other US and International cities. ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... 13, 2015 , ... The added calories and sugar in an average trick-or-treat ... a parent to do? Registered dietitians from Retrofit , the leading corporate weight ... year. , “Halloween is a high-calorie holiday,” said Dara Aronow, Registered Dietitian, Retrofit. ...
(Date:10/13/2015)... ... 2015 , ... Vision Group Holdings, the largest LASIK provider in North America, ... The LASIK Vision Institute and TLC Laser Eye Centers, Vision Group Holdings has performed ... correction. , Global Laser Vision will continue to operate in San Diego as it ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... the United States, today announced the release of its limited edition holiday seasonal ... Cocktail Agua Fresca. All feature the unique flavor combinations and delicious taste Califia ...
(Date:10/13/2015)... ... 13, 2015 , ... ProText Kinetic Panel is a typography creation tool made ... can create energetic text animations in any layout without the use of keyframes. Using ... timeline and stylize the text. With intuitive on-screen controls, users can re-position and scale ...
(Date:10/13/2015)... Williamsport, PA (PRWEB) , ... October 13, 2015 , ... ... (SH) 2015 utility costs were 36 percent lower per square foot than in 2009. ... the actual cost of heating and cooling has decreased by eight percent. , ...
Breaking Medicine News(10 mins):